New Lumicera Facility to Open in Phoenix

November 10, 2016

MADISON, Wis., November 10, 2016–Navitus Health Solutions, LLC, announced today that its specialty pharmacy—Lumicera Health Services—will be expanding to a Western regional location to better serve clients in this geographical area. The facility will be based in Phoenix, Arizona and will serve as a distribution site. Lumicera Phoenix is slated to open on November 14, 2016.

Since opening its Madison, Wisconsin location in 2014, Lumicera’s innovative specialty model has already resonated with clients by generating increased savings at the client and patient level. Consistent with the Navitus model, Lumicera is committed to clinical excellence, member engagement, and lowest-net per member per month cost medication management. Every year millions of dollars in savings from negotiated drug prices and network rate and rebate improvements are passed through to plan sponsors, putting the savings where they belong—with the client and consumer. Lumicera’s unique cost-plus pricing methodology and first-in, first-out pass-through pricing model contribute greatly to enhanced overall savings, resulting in industry-leading drug trend rates that consistently outperform the national trend.

In addition, the URAC-accredited specialty pharmacy offers customizable clinical pathways to support its patients and improve adherence to therapy. Significant improvements have been seen in patients with chronic diseases, such as multiple sclerosis and hepatitis C. Since 2015, 98% of patients have reported that they are satisfied or very satisfied with Lumicera’s services.

The opening of the new Phoenix location will mark another milestone in Navitus’ growth trajectory and allow Lumicera to continue to offer high-touch services—a defining component of the Navitus and Lumicera business model. “As we continue to grow, we are excited to have the opportunity to bring the Lumicera model to more clients to better manage specialty spend and follow through on our commitment to be a patient-centric specialty pharmacy,” noted Brent Eberle, RPh, MBA, Senior Vice President & Chief Pharmacy Officer, Navitus Health Solutions, and General Manager, Lumicera Health Services.

About Lumicera

Headquartered in Madison, Wisconsin, Lumicera functions as a stand-alone URAC-accredited specialty pharmacy while adhering to Navitus’ core principles of transparency and stewardship. Lumicera offers a high-touch, patient-centric approach to care and evidence-based clinical programs and, consistent with the Navitus model, delivers savings through optimized discounts and cost transparency. Lumicera’s pharmacy team keeps patient care at the forefront, providing high-touch, patient-focused services. And with Lumicera’s unique cost-plus pricing model, the actual acquisition cost for the product is passed through to the client. To learn more about Lumicera, visit www.lumicera.com or call 855-847-3554.

About Navitus

Navitus Health Solutions, LLC, a division of SSM Health, is a full-service, URAC-accredited pharmacy benefit management company. As a zero-spread, full pass through pharmacy benefit manager (PBM), Navitus aligns performance with plan sponsors’ benefit goals to deliver comprehensive clinical programs and cost-saving strategies that lower drug trend and promote good member health. Navitus provides its flexible services to government entities, self-funded employers, coalitions, labor organizations, third-party administrators, and health plans, including managed Medicaid, Exchanges and Medicare Part D. For more information about Navitus’ tangible solutions to the rising cost of health care, visit www.navitus.com or call 877-571-7500.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

Empowered by Strategic Opportunities and Service Excellence

Empowered by Strategic Opportunities and Service Excellence

Putnam | Northern Westchester Health Benefits Consortium (PNW HBC) was the first municipal cooperative health plan in the state of New York to become certified by the Department of Insurance. They are dedicated to meeting — and exceeding — the standards…

QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

As part of their treatment plan for hypophosphatasia (HPP), a rare genetic disorder affecting bone and teeth development, one of our members required Strensiq, a medication designed to manage HPP. However, Strensiq’s annual treatment costs ranged from…

RISE: Reporting and Intervention for Stars Excellence

RISE: Reporting and Intervention for Stars Excellence

RISE is a comprehensive Star Ratings Improvement program that focuses on positive outcomes for Medicare Part D (Part D) clinical measures, including: medication adherence for diabetes medications, medication adherence for hypertension, medication adherence…

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Medication Therapy Management: Improving Health Outcomes and Reducing Cost

Patients with chronic diseases can face greater risks for medication-related challenges such as non-adherence. This can lead to poor health outcomes and higher plan costs. That’s why we developed an MTM program, offered through our Clinical Engagement…

Personalized Member Transitions: Creating a Smoother Benefit Transition

Personalized Member Transitions: Creating a Smoother Benefit Transition

Navigating benefit transitions is no easy task. Our personalized member transition (PMT) program makes it smoother for both plan sponsors and members. Through our high-touch outreach to members, we eliminate gaps in care, minimize member disruption, improve…

previous arrow
next arrow